A Trial to Compare Xifaxan to Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhea (CDAD)

NCT00269399 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

237

Enrollment

INDUSTRY

Sponsor class

Conditions

Clostridium Infections
Diarrhea

Interventions

DRUG: Rifaximin (Xifaxan)
DRUG: Vancomycin

Sponsor

Bausch Health Americas, Inc.